Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Apoptosis is an orderly, active process with the activation of certain genes that allows the cell to follow the path of programmed death. During embryogenesis, programmed cell death templates are essential for the proper formation of organs and the functioning of the nervous system in the regression of primary or abnormal structures. Increased cell mortality in the mature nervous system can lead to various neurodegenerative diseases. For these reasons, the Bcl-2 protein family is being studied intensively in connection with the function of the nervous system. Programmed cell death (PCD) makes it possible to eliminate superfluous cells and thus contribute to the maintenance of homeostasis in the body. Malregulation of apoptosis is characteristic of tumour processes, degenerative changes and autoimmune diseases. Research into gene expression of pro- and anti-apoptotic proteins using knock-out technology is currently raising great hopes for the treatment of patients affected by neurodegenerative changes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.18388/pb.2021_460 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!